BACE1 and Alzheimer disease: Membrane ceramides are known to contribute to AD pathology by facilitating the mislocation of BACE1 and γ-secretase to lipid rafts, thereby promoting Aβ formation (Lee et al., 1998; Vetrivel et al., 2005).